KLOW Blend combines BPC-157, TB-500, KPV and GHK-Cu — four peptides frequently stacked together in tissue-repair research. Below, we compare vendors currently stocking research-grade KLOW Blend — not just a single sales page.
Prices and testing claims are pulled from each vendor's product listing. Always confirm current price and COA (Certificate of Analysis) on the vendor's site before buying.
| Vendor | Price | Purity Testing | Code | |
|---|---|---|---|---|
 UK SarmsBest Value |
£60.00 – £85.00 | Third-party COA | Auto-applied | Buy Here → |
 MuscleChem |
£74.99 – £149.99 | In-house testing | Buy Here → | |
 Amino Club |
From $99.99 | Third-party COA | Buy Here → | |
 Amino Vault |
From $106.25 | Third-party COA | Buy Here → | |
 Next Chem |
$168.95 | Third-party COA | Auto-applied | Buy Here → |
 Purity Peptides |
$199.99 | Third-party COA | Buy Here → | |
 American Peptides |
$200.00 | Third-party COA | Buy Here → |
The KLOW Blend combines four peptides studied individually in tissue-repair literature — BPC-157, TB-500, KPV, and GHK-Cu — into a single research formulation. Vendors position it as a broader-spectrum tissue-research combination rather than a single-mechanism compound.
Research-grade KLOW is typically supplied as a lyophilized powder blend in a single vial, with total peptide content commonly listed in the 70–80mg range across the four components, intended for laboratory reconstitution only.
Each component of the blend has been studied through a distinct proposed mechanism — BPC-157 and TB-500 for angiogenesis and cell migration, KPV for anti-inflammatory signaling independent of pigmentation pathways, and GHK-Cu for collagen synthesis and antioxidant gene expression.
Because each individual peptide in the blend has separately been studied for aspects of wound and connective-tissue repair, researchers have explored combination protocols to examine potential additive or complementary effects.
The inclusion of KPV reflects a research interest in anti-inflammatory peptide signaling, an area studied in gut and dermal inflammation models independent of the alpha-MSH pigmentation pathway KPV is derived from.
As a combination of individually under-researched-in-humans peptides, KLOW has not been evaluated as a formulation in controlled human trials. Safety considerations from each individual component (see BPC-157, TB-500, KPV and GHK-Cu listings) apply, and combination-specific interaction data does not exist.
No clinical or FDA-established human dosage exists for this combination product; any research use should reference the individual peptide literature and appropriate laboratory protocols.
Compound X does not sell KLOW Blend (BPC+TB+KPV+Cu) directly. We provide independent research, comparisons and vendor links — see the vendor comparison table above for current US, UK, Canada and Australia options.
See the individual BPC-157, TB-500, KPV, and GHK-Cu research listings for compound-specific peer-reviewed literature.
New guides, vendor comparisons and compound breakdowns every week.